Predicting Risk of Recurrence for Women With DCIS

Commentary
Article

Eileen Rakovitch, MD, associate professor, radiation oncologist, Sunnybrook Health Sciences Centre, Toronto, Ontario, discusses predicting risk of recurrence in women with DCIS.

Clinical Pearls

Eileen Rakovitch, MD, associate professor, radiation oncologist, Sunnybrook Health Sciences Centre, Toronto, Ontario, discusses predicting risk of recurrence in women with DCIS.

  • Oncotype DX DCIS Score was validated as a predictor of risk of recurrence among women treated with breast-conserving surgery alone for DCIS.
  • Women with a low-risk DCIS Score had a significantly lower risk of recurrence.
  • Every 50 point increase in DCIS Score was associated with a two-fold increase in risk of recurrence.

<<<

Go back to the SABCS conference page

Related Videos
Video 3 - "Managing Toxicities and Adverse Reactions in HR+/Her2-Low mBC Therapies"
Video 2 - "EMERALD: Underscoring Key Elacestrant Data + Subgroup Analyses for Informed Therapy Selection"
Video 1 - "A 62-Year-Old Woman with HR+ HER2-low Metastatic Breast Cancer and Lung, Liver, and Bone Metastases and Using Biomarker Testing to Guide Treatment Selection"
Related Content